Thrombosis Journal

Article	Citations
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis	63
Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis	53
Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor	44
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis	41
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review	38
Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity	37
Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis	30
Viscoelastometry for detecting oral anticoagulants	25
Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization	24
Current status of treatment of cancer-associated venous thromboembolism	24
NETosis and SARS-COV-2 infection related thrombosis: a narrative review	24
Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury	24
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis	23
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19	21
High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study	20
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients	18
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials	17
Detailed histological analysis of a thrombectomy-resistant ischemic stroke thrombus: a case report	17
Current and future strategies to monitor and manage coagulation in ECMO patients	17
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia	16
Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis	16
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intens	15
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database	15
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review	15
Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis	15

Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study	14
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis	14
Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study	14
Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report	13
Maternal mortality following thromboembolism; incidences and prophylaxis strategies	13
A review of thromboembolic events in hospitalized COVID-19 patients	13
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis	13
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms	13
ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study	12
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India	12
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism	11
Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients	11
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study	11
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study	11
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia	11
Peripherally inserted central venous catheter in upper extremities leads to an increase in D-dimer and deep vein thrombosis in lower extremities	11
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data	11
Clinical significance of D-dimer levels during acute period in ischemic stroke	11
Clinical significance of neutrophil extracellular traps biomarkers in thrombosis	11
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study	11
Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis	11
Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study	10
Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention	10
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis	10
Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated w	10
Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy	10
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study	10
Incidence and characteristics of arterial thromboemboli in patients with COVID-19	10
Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia	10
Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review	10
Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors	10
Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume	9
Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis	9
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study	9
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study	9
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer	9
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients	9
Tranexamic acid for haemostasis and beyond: does dose matter?	9
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements	9
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand	8
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients	8
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study	8
The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients	8
Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency	8
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study	8
Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study	8
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery	8
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore	8
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study	7
LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation	7

Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	7
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report	7
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis	7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	7
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study	7
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage	7
Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis	7
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis	7
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study	6
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report	6
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	6
A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score	6
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT	6
Platelet indices and blood pressure: a multivariable mendelian randomization study	6
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications	6
Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps	6
JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature	6
Unprovoked internal jugular vein thrombosis: a case report and literature review	6
Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study	6
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines	6
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study	6
Narsoplimab for severe transplant-associated thrombotic microangiopathy	5
Lead thrombus under standard-dose edoxaban in a patient with normal to high creatinine clearance and protein S deficiency	5
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study	5
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study	5
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance	5
Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice	5
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis	5
High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion	5
Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women	5
Structure, signal transduction, activation, and inhibition of integrin αIIbβ3	5
The effect of neutrophil extracellular traps in venous thrombosis	5
Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis	5
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China	5
Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report	5
Risk factors for central venous catheter-associated deep venous thrombosis in pediatric critical care settings identified by fusion model	5
Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia	5
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome	5
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System	5
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19	5
The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review	4
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review	4
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2	4
The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes	4
Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis	4
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review	4
Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review	4
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma	4
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation	4
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to action	4
Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity	4
A catastrophic seronegative anti-phospholipid syndrome: case and literature review	4
Damage-associated molecular patterns and fibrinolysis perturbation are associated with lethal outcomes in traumatic injury	4
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery	4
Long non-coding RNA crnde promotes deep vein thrombosis by sequestering miR-181a-5p away from thrombogenic Pcyox1l	4
Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging	4
Incidence of proximal deep vein thrombosis in medical critical care patients	4
Enoxaparin-induced reactive thrombocytosis: a case report	4
Nonnegligible causes of symptoms of acute lower extremities——3 cases of May-Thurner syndrome with deep vein thrombosis	4
COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab	4
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country	4
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	4
Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome	4
Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer	4
Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies	4
Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a Solent Omni catheter for patients with proximal vein thrombosis	4
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	4
Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation	4
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab	3
Morphologic change in deep venous thrombosis in the lower extremity after therapeutic anticoagulation	3
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks	3
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	3
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	3
Circular RNA ciRs-126 promotes hypoxia/reoxygenation cardiac injury possibly through miR-21	3
Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)	3
Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?	3
Factors influencing DVT formation in sepsis	3
Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study	3
Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice	3
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro	3

A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency	3
Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study	3
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background	3
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis	3
Monitoring coagulation-fibrinolysis activation prompted timely diagnosis of hemophagocytic lymphohistiocytosis-related disseminated intravascular coagulation	3
Evaluation of the analytical performance of the PC100 platelet counter	3
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	3
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism	3
An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature	3
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article	3
Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study	3
Anti-inflammatory and antioxidant efficacy of lavender oil in experimentally induced thrombosis	3
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study	3
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19	3
Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial	3
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	3
Prevalence and risk factor of post-operative lower extremities deep vein thrombosis in patients undergoing gynecologic surgery: a single-institute cross-sectional study	3
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	3
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	3
Neonatal portal vein thrombosis: risk factors, diagnosis, treatment recommendations and review of the literature	3
A cross-sectional, multicenter, observational study to assess the prophylaxis of venous thromboembolism in Lebanese and Jordanian hospitals	3
Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery	3
Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis	3
Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer	3
Oxidative stress in acute pulmonary embolism: emerging roles and therapeutic implications	3
Right heart thrombus in transit and peripherally inserted central catheters	2
Vascular endothelial growth factor and the risk of venous thromboembolism: a genetic correlation and two-sample Mendelian randomization study	2
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	2
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	2
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study	2
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model	2
Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis	2
Soluble P-selectin and correlation with Prothrombin Fragment 1 + 2 in myeloid malignancies in Cipto Mangunkusumo general hospital	2
Thrombotic antiphospholipid syndrome in a child with human immunodeficiency virus: a rare case report	2
The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation	2
A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS1	2
Deep vein thrombosis in a patient with Cronkhite-Canada syndrome: a complex case report	2
Neutrophil levels upon admission for the assessment of acute pulmonary embolism with intermediate- and high-risk: an indicator of thrombosis and inflammation	2
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	2
Successful retrieval of dislocated inferior vena cava filter using double vascular sheaths docking technology: case report	2
Deep venous thrombosis in an individual with statin-exposed anti-SRP myopathy: case report and review of literature	2
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial	2
Longitudinal trajectories of atherogenic index of plasma and risks of cardiovascular diseases: results from the Korean genome and epidemiology study	2
Risk factors and potential predictors of pulmonary embolism in cancer patients undergoing thoracic and abdominopelvic surgery: a case control study	2
Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study	2
Clinical characteristics of venous thromboembolism onset from severe high altitude pulmonary edema in plateau regions	2
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	2
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy	2
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion	2
A prediction nomogram for deep venous thrombosis risk in patients undergoing primary total hip and knee arthroplasty: a retrospective study	2
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores	2
The risk for post-thrombotic syndrome of subjects with deep vein thrombosis in an Indonesian referral hospital: a retrospective cohort study	2
Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction	2
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications	2
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report	2
Acute caval thrombosis leading to obstructive shock in the early post insertion period of an inferior vena cava filter: a case report and literature review	2
Association between obstructive sleep apnea and venous thromboembolism recurrence: results from a French cohort	2
Venous anomalies and thromboembolism	2
Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study	2
Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function	2
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases	2
Progress in the clinical effects and adverse reactions of ticagrelor	2
GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway	2
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia	2
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	2
The serum lipid profiles in immune thrombocytopenia: Mendelian randomization analysis and a retrospective study	2
Prognostic value of characteristics of plaque combined with residual syntax score among patients with STEMI undergoing primary PCI: an intravascular optical coherence tomography study	2
Very severe immune thrombocytopenia following SARS-CoV-2 vaccination requiring splenectomy: a case report	2
How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation	2